Stocks › AZN
ASTRAZENECA PLC
AZN·NYSE·USD
$174.35
-1.06 (-0.60%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
AZN
ASTRAZENECA PLC · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AZNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of AZN by members of U.S. Congress · 56 on record · 10 in the last 12 months
Whale Activity
Position changes in AZN reported for 2026-09-30 by 1589 institutional filers
- Increased542
- New126
- Held205
- Decreased492
- Closed163
- No prior filing61
| Filer | Shares | Value | Change |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 1.6M | $26.41B | increased |
| INVESTOR AB | 51.6M | $8.33B | held |
| VANGUARD CAPITAL MANAGEMENT LLC | 45.7M | $7.37B | increased |
| Capital World Investors | 31.1M | $5.06B | increased |
| WELLINGTON MANAGEMENT GROUP LLP | 30.8M | $5.01B | increased |
| FMR LLC | 29.4M | $4.78B | increased |
| Legal & General Group Plc | 26.2M | $4.27B | increased |
| FRANKLIN TEMPLETON INC | 19.1M | $3.59B | increased |
| PRICE T ROWE ASSOCIATES INC /MD/ | 19.3M | $3.11B | increased |
| VANGUARD ASSET MANAGEMENT, Ltd | 19.1M | $3.09B | increased |
| JPMORGAN CHASE & CO | 18.4M | $3.03B | decreased |
| PRIMECAP MANAGEMENT CO/CA/ | 18.1M | $2.92B | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by AZN insiders, by quarter · Form 4
Recent Insider Transactions
8 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Sharma ManiSee Remarks | Grant / award | +1 | $162.60 | $163 | Sep 8, 2026 | Form 4 ↗ |
| Sharma ManiSee Remarks | Purchase | +20 | $160.57 | $3K | Aug 8, 2026 | Form 4 ↗ |
| Sharma ManiSVP, Group Controller | Grant / award | +2 | $163.34 | $327 | Aug 6, 2026 | Form 4 ↗ |
| Sharma ManiSee Remarks | Grant / award | +2 | $190.43 | $381 | Jul 6, 2026 | Form 4 ↗ |
| Sharma ManiSee Remarks | Grant / award | +1 | $179.75 | $180 | Jun 8, 2026 | Form 4 ↗ |
| Sharma ManiSee Remarks | Sale | −11.9K | $185.78 | $2.2M | May 20, 2026 | Form 4 ↗ |
| Sharma ManiSee Remarks | Grant / award | +1 | $186.28 | $186 | May 6, 2026 | Form 4 ↗ |
| Sharma ManiSee Remarks | Grant / award | +1 | $196.03 | $196 | Apr 7, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding AZN · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Nuveen International Equity Index Fund TIAA-CREF Funds | 2.4M | $412.1M | 1.15% | Jul 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 2.1M | $388.9M | 0.27% | Jun 30, 2026 |
| Six Circles International Unconstrained Equity Fund SIX CIRCLES TRUST | 1.7M | $315.8M | 1.46% | Jun 30, 2026 |
| Parnassus Core Equity Fund Parnassus Funds II | 1.7M | $279.0M | 1.30% | Sep 30, 2026 |
| Bridge Builder International Equity Fund Bridge Builder Trust | 1.3M | $241.1M | 0.94% | Jun 30, 2026 |
| Six Circles Managed Equity Portfolio International Unconstrained Fund SIX CIRCLES TRUST | 1.2M | $229.6M | 1.57% | Jun 30, 2026 |
| Disciplined Value Fund John Hancock Funds III | 1.1M | $216.3M | 1.10% | Jun 30, 2026 |
| Invesco Comstock Fund AIM Sector Funds (Invesco Sector Funds) | 870.7K | $148.1M | 0.99% | Jul 31, 2026 |
| Harding Loevner International Equity Portfolio HARDING LOEVNER FUNDS INC | 680.1K | $129.3M | 1.05% | Apr 30, 2026 |
| College Retirement Equities Fund - Global Equities Account College Retirement Equities Fund | 673.0K | $125.6M | 0.32% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list AZN's shares (CUSIP G0593M107), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming astrazeneca as client
- TARPLIN, DOWNS & YOUNG, LLCASTRAZENECA · 2026 Q3 · BUD, MMM, HCR$80K
Filing ↗ - TIBER CREEK GROUPASTRAZENECA · 2026 Q3 · MMM, HCR$80K
Filing ↗ - TIBER CREEK GROUPASTRAZENECA · 2026 Q2 · HCR, FOR, DEF, MMM$80K
Filing ↗ - TARPLIN, DOWNS & YOUNG, LLCASTRAZENECA · 2026 Q2 · BUD, MMM, HCR$80K
Filing ↗ - TARPLIN, DOWNS & YOUNG, LLCASTRAZENECA · 2026 Q1 · BUD, MMM, HCR$80K
Filing ↗
Government Contracts
Federal awards to ASTRAZENECA PLC · USAspending
No federal contract awards found for ASTRAZENECA PLC.
U.S. Patents
Recent USPTO applications naming ASTRAZENECA PLC
No USPTO patent applications found for ASTRAZENECA PLC.
Annual Financials
From AZN's 10-K filings · XBRL
SEC holds no annual XBRL figures in US dollars for ASTRAZENECA PLC.
Stock Splits
Every split and reverse split in the price history
- 1-for-2Reverse splitFeb 2, 2026
- 2-for-1Stock splitJul 27, 2015
- 3-for-1Stock splitApr 8, 1998
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About ASTRAZENECA PLC
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersCAMBRIDGE
IncorporatedX0
SEC CIK0000901832 ↗
Former namesZENECA GROUP PLC











